Neuland Laboratories' Stock Surges 5.91%, Outperforms Sector by 4.33%
Neuland Laboratories, a midcap pharmaceutical company, has shown a strong upward trend in the stock market with a 5.91% gain on November 5th, 2024. The stock has consistently outperformed the sector for the past two days, with a total rise of 7.57%. It is currently trading higher than its moving averages, indicating potential for further growth.
Neuland Laboratories, a midcap pharmaceutical company, has been making waves in the stock market with its recent performance. On November 5th, 2024, the company's stock gained 5.91%, outperforming the sector by 4.33%. This positive trend has been consistent for the past two days, with a total rise of 7.57% in returns.
The stock's day's high was recorded at Rs 15582.45, a 5.02% increase from the previous day. This is a significant achievement for Neuland Laboratories, as it shows a strong upward momentum in the market.
In addition, the company's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend and a potential for further growth in the future.
Neuland Laboratories' performance has also outshined the overall market, with a 1-day performance of 5.71% compared to the Sensex's 0.00% performance. In the past month, the company's stock has seen a 29.06% increase, while the Sensex has seen a -3.56% decrease.
With its strong performance and consistent growth, Neuland Laboratories is a stock to watch out for in the pharmaceutical industry. Investors can take note of MarketsMOJO's 'Buy' call for the company's stock, as it shows potential for further growth and success in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
